Trial Details

Not Recruiting
Basic Information
Clinical ID c5363
Identifier CTRI/2023/10/058514
Trial Title Evaluation of effectiveness and safety of oral tofacitinib in patients with Parthenium dermatitis: A prospective interventional open label study - NIL
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Health Condition 1: L237- Allergic contact dermatitis due toplants, except food
Interventions Intervention1: Oral Tofacitinib: Tofacitinib is an oral JAK 1/3 inhibitor which has been approved for the treatment of rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease and has been used to treat other autoimmune disease such as al
Participant Information
Sponsor AIIMS, New Delhi
City NULL
Country/Region India
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement NULL
Study Design
Study Type Interventional
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL